VYYRF (Voyageur Pharmaceuticals) FCF Margin %: -864.29% (As of Feb. 2026)


VYYRF Voyageur Pharmaceuticals Ltd VYYRF
18 GF Score
Price $0.10
! 5 Warning Signs
View Full Analysis

What is Voyageur Pharmaceuticals FCF Margin %?

Voyageur Pharmaceuticals VYYRF +7.71% 18 FCF Margin % is -864.29% as of Feb. 2026. GuruFocus rates VYYRF with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 955 Drug Manufacturers companies, Voyageur Pharmaceuticals ranks worse than 98.95% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Voyageur Pharmaceuticals's Free Cash Flow for the three months ended in Feb. 2026 was $-0.12 Mil. Voyageur Pharmaceuticals's Revenue for the three months ended in Feb. 2026 was $0.01 Mil. Therefore, Voyageur Pharmaceuticals's FCF Margin % for the quarter that ended in Feb. 2026 was -864.29%.

As of today, Voyageur Pharmaceuticals's current FCF Yield % is -7.71%.

The historical rank and industry rank for Voyageur Pharmaceuticals's FCF Margin % or its related term are showing as below:

VYYRF' s FCF Margin % Range Over the Past 10 Years
Min: -24108.33   Med: -24108.33   Max: -6369.57
Current: -6369.57

During the past 13 years, the highest FCF Margin % of Voyageur Pharmaceuticals was -6369.57%. The lowest was -24108.33%. And the median was -24108.33%.

VYYRF's FCF Margin % is ranked worse than
98.95% of 955 companies
in the Drug Manufacturers industry
Industry Median: 2.51 vs VYYRF: -6369.57

Voyageur Pharmaceuticals FCF Margin % Related Terms

Voyageur Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Voyageur Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals FCF Margin % Chart

Voyageur Pharmaceuticals Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -22,866.67

Voyageur Pharmaceuticals Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -8,000.00 -26,300.00 -864.29

VYYRF vs ZTS, UTHR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Voyageur Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Voyageur Pharmaceuticals's FCF Margin % falls into.


VYYRF
18GF Score
Voyageur Pharmaceuticals Ltd VYYRF
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyageur Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Voyageur Pharmaceuticals's FCF Margin for the fiscal year that ended in Nov. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Nov. 2025 )/Revenue (A: Nov. 2025 )
=-2.058/0.009
=-22,866.67 %

Voyageur Pharmaceuticals's FCF Margin for the quarter that ended in Feb. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-0.121/0.014
=-864.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -864.29% mean?
Voyageur Pharmaceuticals (VYYRF) has a FCF Margin % of -864.29% as of Feb. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Voyageur Pharmaceuticals and its competitors. According to the industry distribution chart, Voyageur Pharmaceuticals ranks #945 out of 955 companies in the Drug Manufacturers industry, placing it in the top 99%.
Is Voyageur Pharmaceuticals' FCF Margin % too high?
Voyageur Pharmaceuticals' current FCF Margin % is -864.29%. Based on the distribution chart, Voyageur Pharmaceuticals ranks #945 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Voyageur Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Voyageur Pharmaceuticals' FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Voyageur Pharmaceuticals ranks #945 out of 955 companies for FCF Margin %. This places Voyageur Pharmaceuticals in the lower half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Voyageur Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Voyageur Pharmaceuticals's current FCF Margin % is -864.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyageur Pharmaceuticals stock overvalued right now?
Voyageur Pharmaceuticals (VYYRF) has a current FCF Margin % of -864.29%. The current FCF Margin % is -864.29%. Voyageur Pharmaceuticals' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Voyageur Pharmaceuticals (VYYRF), the current FCF Margin % is -864.29% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Voyageur Pharmaceuticals Business Description

Other Exchanges VM:Canada
Address 4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
18GF Score

Get the complete analysis for VYYRF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price